Nanobiotix NBTX Balance Sheet (2018-2025)

NASDAQ NBTX
$36.64 -1.55 (-4.06%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Nanobiotix Quarterly Balance Sheet

Periods 14 quarters
Latest Dec 2025

Nanobiotix reported total assets of $78.88M and total liabilities of $177.22M for the quarter ended Dec 2025, down 21.9% year over year. This balance sheet covers 14 quarters of results from Dec 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2018 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 41.32M38.85M29.29M142.06M123.24M96.00M67.25M42.23M23.55M81.00M71.44M53.15M32.62M61.40M
Short-term InvestmentsInvestments (Current) 142.06M136.31M0.38M42.23M23.55M81.00M80.45M56.30M61.40M
Cash & Current Investments 41.32M38.85M29.29M284.13M123.24M232.31M67.62M84.45M47.10M162.00M71.44M133.60M88.92M122.81M
Receivables - NetNet Receivables 0.01M0.07M0.25M0.10M1.19M0.97M3.36M3.21M2.08M2.49M
Receivables - OtherOther Receivables -1.01M-9.04M-0.72M-0.32M2.22M0.17M
Receivables 0.01M0.07M-9.04M-0.46M0.10M0.87M3.19M3.53M3.21M2.08M2.49M
Prepaid Assets 12.20M7.20M16.30M10.45M10.24M11.09M11.88M9.78M11.85M9.35M10.45M9.15M
Current Assets 48.68M51.06M149.33M139.54M106.46M77.74M53.42M36.62M93.97M86.64M65.68M45.15M73.04M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 9.57M10.39M9.84M9.07M9.36M7.91M7.26M7.06M6.73M6.36M5.92M5.50M5.32M
Intangibles 0.12M0.18M0.03M0.01M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M
Goodwill & Intangibles 0.12M0.18M0.03M0.01M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M
Non-Current Assets 4.05M11.16M10.47M9.69M9.96M8.29M7.56M7.38M7.06M6.70M6.36M5.98M5.83M
Assets 52.73M62.21M159.80M149.23M116.42M86.03M60.98M44.00M101.03M93.34M72.04M51.14M78.88M
Liabilities
Current Liabilities
Accounts Payables 8.60M8.47M10.61M7.42M9.86M9.82M18.20M19.62M20.61M21.41M13.17M10.62M
Notes Payables 3.62M6.39M5.94M5.54M5.30M6.32M0.70M0.69M0.49M0.84M
Payables 8.60M12.09M17.01M13.35M15.40M15.11M24.52M20.32M20.61M22.10M13.66M11.46M
Accumulated Expenses 9.26M10.61M8.13M9.86M9.82M18.20M19.62M21.41M22.68M23.32M
Other Accumulated Expenses 5.89M0.03M8.37M6.64M6.04M7.86M6.99M6.72M8.21M7.83M8.06M7.92M8.65M
Short term Debt 1.21M5.81M8.10M9.39M9.71M4.65M10.86M5.40M5.38M5.26M5.36M5.02M
Current Leases 1.43M1.44M1.37M1.20M1.15M1.25M1.29M1.35M1.43M1.47M
Current Deferred Revenue 19.94M18.90M17.80M0.06M0.15M0.14M0.11M0.07M0.06M0.05M
Total Current Liabilities 13.24M15.88M22.70M45.81M42.15M45.44M38.70M54.29M60.86M29.68M4.65M3.75M
Non-Current Liabilities
Non-Current Debt 22.85M48.08M52.59M52.97M43.26M38.42M49.59M47.94M49.00M47.56M49.13M52.64M105.94M
Non-Current Deffered Revenue 7.98M
Pension -0.04M-0.05M-0.04M-0.04M-0.04M-0.05M
Operating Leases 6.93M6.01M6.17M5.75M5.50M4.97M4.91M4.15M3.36M3.46M
Other Non-Current Liabilities 58.40M61.08M56.03M49.11M54.25M58.80M57.21M54.39M58.00M110.96M
Total Non-Current Liabilities 23.24M48.44M53.08M53.52M43.62M38.68M49.87M48.28M49.35M55.93M79.28M57.83M110.28M
Total Liabilities 64.32M66.87M71.69M60.06M57.99M64.06M79.99M103.01M116.80M142.25M129.19M177.22M
Shareholder's Equity
Total Debt 22.85M49.29M62.01M67.47M58.59M53.67M59.54M65.12M55.10M52.95M55.09M58.49M111.80M
Common Equity -2.11M84.02M49.89M30.65M1.91M-27.59M-58.57M-1.98M-23.45M-70.21M-78.05M-98.34M
Liabilities and Shareholders Equity 52.73M62.21M159.80M149.23M116.42M86.03M60.98M44.00M101.03M93.34M72.04M51.14M78.88M
Treasury Shares 0.19M-0.23M-0.26M-0.23M-0.26M-0.23M-0.25M-0.25M-0.25M-0.24M-0.26M-0.27M
Retained Earnings 0.48M0.66M0.62M-53.77M-244.46M0.71M-308.12M0.79M-338.77M0.76M0.78M0.81M